About us

Interactively procrastinate high-payoff content without backward-compatible data. Quickly cultivate optimal processes and tactical architectures. Completely iterate covalent strategic theme areas via accurate e-markets.

About AmwerkWho we are?About us

Amwerk supports customers through every step of the manufacturing process. From prototyping to delivery, each customer is assigned a dedicated support team to seamlessly move programs through production.

At Kcat Enzymatic, we constantly work towards ensuring access to high quality and economically viable engineered enzymes to support the reduction in carbon footprint, for sustainability and a greener environment; this is the reason why we have been trusted by leading pharmaceutical companies and enzyme stakeholders across the globe. Choose Our Technology For Better Tomorrow

WHAT WE DO

Choose our technology for better tomorrow

KCAT ENZYMATIC is an enzyme/protein engineering group that specializes in providing optimized enzymes for industrial applications.

Our mission is to develop tools and technologies using Quantum Mechanics and Artificial Intelligence to delineate structure-function relationships of enzymes.

https://kcat.co.in/wp-content/uploads/2022/06/Biocatalysis.png

HOW WE DO

https://kcat.co.in/wp-content/uploads/2022/11/how-we-do.jpg

END TO END PROTEIN OPTIMISATION SOLUTION

Kcat Enzymatic is an enzyme/protein engineering group that specializes in providing optimised enzymes for your applications. We explore the transition and intermediate states of biocatalytic reactions and capture transient events of a reaction at the atomic and electronic level. We implement our internally developed algorithms to examine and derive focused libraries of enzymes with desired properties.
https://kcat.co.in/wp-content/uploads/2022/05/Enzymatic_Decoding.jpg

ENZYMATIC DECODING ®

Using our proprietary method ENZYMATIC DECODING ®, we discover new biocatalytic routes for chemistries using Active Site Repurposing Technology. We have developed an in-house database that contains ~35000 enzyme structures integrated into quantum chemical grids. The objective is to find non-infringing enzymes for existing biocatalytic reactions and identify new enzymatic routes for tough chemical reactions.
https://kcat.co.in/wp-content/uploads/2022/05/Industrial_Scale_up.jpg

INDUSTRIAL SCALE-UP

Our end products are enzyme samples that are tailored to match a specific cost
window. This must be tested at the Scale-up industrial bioprocess production level; it
starts from enzyme engineering, and organism engineering to large-scale process optimization. What was at the lab-scale production previously (gram level production) has been upgraded to kilogram scale level production using both engineered enzymes and organisms.

Our Team

Slide VISION To make chemistries and chemical reactions possible and economically viable using enzymes and improve existing enzymes. To make a greener world; a technology rollout from India. Slide MISSION To use/develop computational chemistry and Artificial Intelligence based technologies to engineer/design enzymes. Slide STATEMENT Focussed on discovery and innovation, clearly defined technology transfer, persistence in not only solving the problem but standing with the customers till the product reaches the market.
Kcat_insilico
Kcat_insilico2
AI_website_1

KCAT- COMPUTATIONAL LAB

Our computational lab situated in Queens Road, Bangalore, houses A100, A6000, HPCs, RTX Work stations, Summing up to 62000 CUDA cores

Algorithms implementing Newtonian law of motion and Schrodinger’s equation combined with artificial intelligence are our favourites. In this process, we build both hardware and algorithms which synchronize to scale up the molecular-level understanding of enzymatic reactions.

Our team develops algorithms to study the mysterious nature of enzymes, mechanistic details of reactions, and atomistic and energetic details of chemical reactions fitted inside an enzyme; to engineer industrially viable biocatalysts.

For example, let us jot down some of the challenges in this field like the impact of higher substrate concentration, temperature, and varying pH on the enzymes in a bioreactor. All of the above are rate-limiting factors in whole-cell biocatalysis and can be solved using computational methods.

KCAT- COMPUTATIONAL LAB

Our computational lab situated in Queens Road, Bangalore, houses A100, A6000, HPCs, RTX Work stations, Summing up to 62000 CUDA cores

Algorithms implementing Newtonian law of motion and Schrodinger’s equation combined with artificial intelligence are our favourites. In this process, we build both hardware and algorithms which synchronize to scale up the molecular-level understanding of enzymatic reactions.

Our team develops algorithms to study the mysterious nature of enzymes, mechanistic details of reactions, and atomistic and energetic details of chemical reactions fitted inside an enzyme; to engineer industrially viable biocatalysts.

For example, let us jot down some of the challenges in this field like the impact of higher substrate concentration, temperature, and varying pH on the enzymes in a bioreactor. All of the above are rate-limiting factors in whole-cell biocatalysis and can be solved using computational methods.

KCAT- BIOTECHNOLOGY LAB

Our Biotech Lab is situated in Bangalore Bioinnovation Centre (BBC), Electronic City, Bangalore. A formidable team with 36 years of cumulative experience in cloning and protein expression. The lab has the technical capabilities, manufacturing capacities, and geographical reach to excel and grow

The lab facility can execute high throughput screening of enzyme variants and develop enzyme assays for scale-up biocatalysis.

At present, we can produce enzymes and test up to 30 g/L of substrate conversion. We are also developing a faster method for engineering enzymes integrated with cutting-edge technology CRISPR-Cas9.

Amwerk is the answer

Look no further

Our team

We’re passionate about serving our clients to the fullest, while continuously growing, learning, and innovating. With competencies across multiple industries, we offer our customers a more reliable supply chain and confidence in the long life of their program.

Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. User generated content in real-time will have multiple touchpoints for offshoring.

Capitalize on low hanging fruit to identify a ballpark value added activity to beta test. Override the digital divide with additional clickthroughs from DevOps. Nanotechnology immersion along the information highway loop .

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits.

Completely synergize resource taxing relationships via premier niche markets. Professionally cultivate one-to-one customer service with robust ideas. Dynamically innovate resource-leveling customer service for state of the art customer service.

Amwerk vision

Phosfluorescently engage worldwide methodologies with web-enabled technology. Interactively coordinate proactive e-commerce via process-centric “outside the box” thinking. Completely pursue scalable customer service through sustainable potentialities.

Collaboratively administrate turnkey channels whereas virtual e-tailers. Objectively seize scalable metrics whereas proactive e-services. Seamlessly empower fully researched growth strategies and interoperable internal or “organic” sources.

Credibly innovate granular internal or “organic” sources whereas high standards in web-readiness. Energistically scale future-proof core competencies vis-a-vis impactful experiences.

Interactively procrastinate high-payoff content without backward-compatible data. Quickly cultivate optimal processes and tactical architectures. Completely iterate covalent strategic theme areas via accurate e-markets, media information without cross-media value.

Give us a call
414-214-0362
Cleveland
3644 Rocky River Drive, Ohio 44111, United States
Michigan
1099 Springland Ave, Indiana 46360, United States
Founder and owner

Peter Trebuchet

  • Career & Experience
  • Recognitions & Awards

Progressively maintain extensive infomediaries via extensible niches. Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for interoperable meta-services.

Proactively fabricate one-to-one materials via effective e-business. Completely synergize scalable e-commerce rather than high standards in e-services. Assertively iterate resource maximizing products after leading-edge intellectual capital.

Who is Amwerk?

A team of highly skilled manufacturers, prepared to meet any request for fabrication, tool crafting or product design and production.

More from AmwerkAmwerk services

Intrinsically incubate intuitive opportunities and real-time potentialities. Appropriately communicate one-to-one technology after plug-and-play networks.

01Parts production

Quickly coordinate e-business applications through revolutionary catalysts for change. Seamlessly underwhelm optimal testing procedure processes.

02Precision & quality

Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for interoperable meta-services.

03Auto & aero manufacture

Dramatically engage high-payoff infomediaries rather than client-centric imperatives. Efficiently initiate world class applications after centric infomediaries.

04Quality replacement parts

Phosfluorescently expedite impactful supply chains via focused results. Holistically generate open-source applications through bleeding-edge sources.

Our leadership

https://kcat.co.in/wp-content/uploads/2022/05/New-Project-2.jpg
Pravin Kumar
He has a double doctorate in Computational Biology & Chemistry and Protein engineering. With 18 years of industrial experience working on different projects related to target deconvolution studies and enzyme engineering studies, his main interest is to develop technologies that make enzyme engineering and protein optimization, easy & faster to accelerate economic growth and opportunity.
https://kcat.co.in/wp-content/uploads/2022/05/Gladstone-Sigamani.jpg
Gladstone Sigamani
He holds an M.Tech in Machine Learning and has been in the Software Industry for 10 years. He has a strong technical expertise in Artificial Intelligence and different programming languages. He is highly fascinated by the way proteins and enzymes work and hence currently is pursuing research in understanding the proteins with AI. He implements AI to tap crucial information about how a single mutation can change the stereospecificity of a protein.
https://kcat.co.in/wp-content/uploads/2022/05/New-Project-3.jpg
Roopa Lalitha
She is a Computational Biologist and has a Ph.D. in Computational Biology. She comes with 14 years of experience in Computational chemistry/ Biology, and also is pursuing her second Ph.D. in Protein Engineering. She has extensive research expertise and has several international publications.
https://kcat.co.in/wp-content/uploads/2022/05/Our_Partners.jpg

Our History

2018

August 2018

Kcat’s Inception in Paris in EuroSciCon

https://kcat.co.in/wp-content/uploads/2022/05/Picture1-768x512.jpg

Oct 4th, 2018

Started Office in Co-working space – 3 Founders, just 2 Interns, No Employees, No Projects

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

March 2019

Our dedicated Computational facility in Cox Town from co-working space

Sep 2019

Kcat’s 7D Grid Technology was recognized as “Novel Tools in Enzyme Engineering” Enzyme Engg Consortium.

https://kcat.co.in/wp-content/uploads/2022/05/7D_Grid-768x596.png

Oct 2019

Pfizer visits Kcat’s Office in Cox Town

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

March 2020

Kcat’s Molecular Biology Facility in Bangalore Bioinnovation Center

https://kcat.co.in/wp-content/uploads/2022/05/kcat_biotech_lab4-768x432.png

July 2020

Kcat received the Prestigious BIRAC BIG Grant from the Dept. of Biotechnology, India.

https://kcat.co.in/wp-content/uploads/2022/05/Birac-768x525.jpg

August 2020

Kcat receives 2 back-to-back UKRI Grants

https://kcat.co.in/wp-content/uploads/2022/05/UKRI-768x416.png
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

Jan 2021

Building of Enzyme Libraries – Engineered  Enzyme Kits for diverse applications – Own Products

July 2021

 Hon’ble Finance Ministers Smt. Nirmala Seetharaman’s Visit

https://kcat.co.in/wp-content/uploads/2022/05/Nirma-768x512.jpg

August 2021

Established Fermentation Capabilities & gram scale protein production.

https://kcat.co.in/wp-content/uploads/2022/05/Fermentor.jpg

Sep 2021

Kcat releases 7 products – Engineered Enzyme Kits for diverse biocatalysis applications

https://kcat.co.in/wp-content/uploads/2022/06/histroy-1-1.png

Oct 2021

Supplied the Engineered Enzyme Kits to domestic and International Customers in Germany & UK

Oct 2021

Kcat received the Prestigious National Institute of Health (NIH) – USA

https://kcat.co.in/wp-content/uploads/2022/05/NIH-768x432.jpeg

Nov 2021

Signed Contracts for Enzyme Manufacturing & Continuous Supply of Enzymes

Dec 2021

Established manufacturing of Engineered Lipase through contract manufacturing mode at Kilogram scale.

Dec 2021

 Got some promising results in engineering flourinase – the toughest Enzyme Engineering Problem

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2022

Jan 2022

KCAT Filed its First International Patent – 7D Grid & CRISPR Cas Technology

https://kcat.co.in/wp-content/uploads/2022/05/crisp2-768x432.png

Feb 2022

KCAT Published its research work in top journals in ACS Catalysis,  Catalysis Today, Journal of Biological Chemistry

https://kcat.co.in/wp-content/uploads/2022/05/Picture3-768x667.jpg

Mar 2022

Automated Lab for Enzyme Screening

April 2022

Kcat manuscript, “Structure dynamics and molecular inhibition of the Staphylococcus aureus m1A22-tRNA methyltransferase TrmK” has been selected as one of JBC’s “Editors Picks”.

https://kcat.co.in/wp-content/uploads/2022/06/histroy-2.jpg

May 2022

Kcat is once again recognized by the “Enzyme Engineering Consortium”.

Texas Dallas/Fort Worth

https://kcat.co.in/wp-content/uploads/2022/05/May2022-768x733.jpg
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2023

March 2023

Kcat Enzymatic has successfully secured its first investment from Ideaspring Capital, marking a significant milestone in our journey towards creating a sustainable future for a more resilient tomorrow.

April 2023

We are extremely delighted to see you all at CPHI North America 2023. Come visit us at our booth #135.
Feel free to get in touch with us to discover how our state-of-the-art AI-powered technology can revolutionize your manufacturing process with novel biocatalytic routes.

October 2023

Our scientist Naveen, Gladstone & Pravin presenting the posters to Scientists at Enzyme Engineering Conference XXVII, Singapore-2023
#kcat #EEC #XXVII

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]